TP53 and neoplasm: Genomic p53 sequencing is generally considered to be the gold standard against which new p53 assessment methods should be compared, but complete detection of mutations in formalin fixed tissue requires microdissection of tumour samples, a time-consuming procedure when hundreds of samples must be tested (Hartmann et al, 1997).